Cash and prizes boost HIV pill taking in uganda trial
NCT ID NCT05378607
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether offering small prizes (phone credit) can encourage young people aged 15-30 with HIV to take their medication every day. 560 participants in Uganda are split into groups with different reward rules. The goal is to see if these low-cost incentives improve adherence and viral suppression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- incentive program (prize drawings for airtime rewards)
- What this could lead to
- If successful, this could show that simple, low-cost rewards help people stick to their HIV medication, improving health and reducing virus spread.
- What could go wrong
- This is a behavioral study, not a medical treatment. The effect may be small or not last long, and results may not apply to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ART are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mildmay Uganda
Kampala, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Choice may boost HIV prevention: a trial tests offering multiple PrEP options to young women in kenya
- Home care plus nutrition may cut post-hospital deaths in HIV — a trial puts it to the test
- Heavy drinking and risky sex: a text-based intervention aims to cut HIV risk
- Pharmacists on the front line: a new strategy to fight heart disease in people with HIV
- Early HIV treatment may shield immune cells from lasting damage